
AdvaMed® Best Practice Guidance on Value-Based Arrangements
These arrangements to advance value-based care are designed to increase shared accountability among shareholders for quality of, access to and/or the total cost of care.
Learn more about our Legal work.
These arrangements to advance value-based care are designed to increase shared accountability among shareholders for quality of, access to and/or the total cost of care.
AdvaMed® publishes a quarterly attorney ad spend tracker, which highlights the amount of money spent on medical device mass tort television advertising.
Sidley’s Global Life Sciences group looks at 12 forces driving the life sciences legal and regulatory landscape in 2022, and provides practical tips on a range of topics for life…
Non-lawyer firm ownership poses particular risks to the medical device industry and the patients & care givers medtech innovators serve every day.
As medtech innovation outpaces coding and payment systems designed for another era, the threat of meritless False Claims Act cases deters important advancement in technologies patients need.
The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from Pat Fogarty, Senior Vice President, Deputy General Counsel & Director of Litigation regarding this week’s filing of an amicus…
Learn about how recent developments in patent law affect FTO assessments.
Join us for our webinar with Sidley Austin to better understand the current health care enforcement landscape with the new administration.
This piece shines light on this mass tort generation machine against medical device manufacturers, explaining how it works and cautioning against the impact it is having on American healthcare.
AdvaMed® and its member companies created a comprehensive toolkit for use by all organizations in the global medical technology supply chain.